Mrna Fund II L.P.
Oxford Bioscience · adviser of record: Oxford Bioscience III Corporation · 2011 vintage
Mrna Fund II L.P. is a 2011 venture fund managed by Oxford Bioscience. It reported $193k in gross assets at year-end 2017, against a peak of $1mm in 2011.
- Latest value held
- $193k year-end 2017
- Peak
- $1mm year-end 2011
- Fund size
- Not on file
Value held by year-end
Gross asset value reported on Form ADV at each year-end. Open in the Fund Tracker
| Year-end | Gross assets | ÷ size | Change |
|---|---|---|---|
| 2017 | $193k | – | +0% |
| 2016 | $193k | – | +0% |
| 2015 | $193k | – | -76% |
| 2014 | $796k | – | +0% |
| 2013 | $796k | – | +0% |
| 2012 | $796k | – | -24% |
| 2011 | $1mm | – | – |
Other funds from Oxford Bioscience
- Oxford Bioscience Partners V L.P. 2011
- Oxford Bioscience Partners IV L.P. 2011
- Korea-Seoul Life Science Fund 2011
- Oxford Bioscience Partners II L.P. 2011
- Oxford Bioscience Partners (Bermuda) II Limited Partnership 2011
- Oxford Bioscience Partners III L.P. 2011
- Oxford Bioscience Partners (GS-Adjunct) II L.P. 2011
- Mrna Fund V L.P. 2011
- Oxford Bioscience Partners II Annex L.P. 2011
- Oxford Bioscience Partners (Adjunct) II L.P. 2011
About these numbers
Gross asset value is what the manager reports holding in the fund at each fiscal year-end, on SEC Form ADV, Schedule D. It includes the GP’s own commitment and is before carried interest, so it is not the LPs’ net return, and it does not show cash already distributed. A fall in value can mean distributions, markdowns or both. Fund size is the amount sold reported on Form D, which for some funds reflects only a first close. Private fund ID 805-8238955663. Data updated October 13, 2026.
Is this your fund?
Spot an error and email a correction. Facing DPI pressure? See how distribution financing works.